ZNF250
Zinc finger protein 250
Also known as: MGC9718, ZFP647, ZN250_HUMAN, ZNF647
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15622
- Gene
- ZNF250
- Ensembl
- ENSG00000196150
- Chromosome
- 8
- Canonical length
- 560 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
Enables identical protein binding activity and sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
560 residues, UniProt reviewed canonical sequence.
>P15622|ZNF250
1 MAAARLLPVP AGPQPLSFQA KLTFEDVAVL LSQDEWDRLC PAQRGLYRNV MMETYGNVVS
61 LGLPGSKPDI ISQLERGEDP WVLDRKGAKK SQGLWSDYSD NLKYDHTTAC TQQDSLSCPW
121 ECETKGESQN TDLSPKPLIS EQTVILGKTP LGRIDQENNE TKQSFCLSPN SVDHREVQVL
181 SQSMPLTPHQ AVPSGERPYM CVECGKCFGR SSHLLQHQRI HTGEKPYVCS VCGKAFSQSS
241 VLSKHRRIHT GEKPYECNEC GKAFRVSSDL AQHHKIHTGE KPHECLECRK AFTQLSHLIQ
301 HQRIHTGERP YVCPLCGKAF NHSTVLRSHQ RVHTGEKPHR CNECGKTFSV KRTLLQHQRI
361 HTGEKPYTCS ECGKAFSDRS VLIQHHNVHT GEKPYECSEC GKTFSHRSTL MNHERIHTEE
421 KPYACYECGK AFVQHSHLIQ HQRVHTGEKP YVCGECGHAF SARRSLIQHE RIHTGEKPFQ
481 CTECGKAFSL KATLIVHLRT HTGEKPYECN SCGKAFSQYS VLIQHQRIHT GEKPYECGEC
541 GRAFNQHGHL IQHQKVHRKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF250 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 9.3 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 9.3 nTPM
- skin: 8.5 nTPM
- cerebellum: 8.2 nTPM
- ovary: 8.2 nTPM
- retina: 7.3 nTPM
- endometrium: 6.9 nTPM
Single-cell type
- neutrophils: 95 nCPM
- nk-cells: 45 nCPM
- podocytes: 43 nCPM
- cardiomyocytes: 40 nCPM
- early primary spermatocytes: 38 nCPM
- plasma cells: 37 nCPM
Immune cell
- T-reg: 12 nTPM
- gdT-cell: 11 nTPM
- memory B-cell: 10 nTPM
- naive B-cell: 9.8 nTPM
- naive CD4 T-cell: 8.9 nTPM
- MAIT T-cell: 8.1 nTPM
Brain region
- cerebellum: 30 nTPM
- hypothalamus: 18 nTPM
- cerebral cortex: 16 nTPM
- midbrain: 16 nTPM
- pons: 16 nTPM
- white matter: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.28
- gnomAD missense Z
- 2.34
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF250 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF250 as an antibody target. Whether an autoantibody or antibody against ZNF250 could matter depends on whether native ZNF250 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF250 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF250 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...